摘要
目的:研究DNA修复酶(O-methylguanine-DNA methyltransferase,MGMT)在乳腺癌中的表达及其临床意义。方法:乳腺癌和腺瘤标本共计143例,10%福尔马林固定,石蜡包埋,采用SABC免疫组织化学方法检测MGMT表达。结果:MGMT在乳腺癌和乳腺腺瘤中的阳性率分别为57.85%和13.64%,组间比较具有显著性差异。MGMT在乳腺癌中的表达与患者的年龄、淋巴结转移有关。结论:MGMT的异常表达与乳腺癌的淋巴结转移有关;MGMT可以作为判断乳癌发生和预后的重要指标;检测其表达可以指导临床上化疗方案的制定。
Objective: To investigate the expression of MGMT in breast cancer and its clinical significance. Methods: Total of 143 specimens from breast adenoma and breast cancer were tested by immunohistochemical technique MGMT. Results: The positive rate of MGMT in breast cancer was 57.85% ,while 13.64% in breast adenoma, there was significant difference between the two groups. The expression of MGMT was correlated with the patients'age and lymph node metastasis. Conclusion: Abnormal expression of MGMT was associated with lymph node metastasis; It could be a useful index for the primary screening and the prognosis of breast cancer.
出处
《现代肿瘤医学》
CAS
2008年第9期1499-1501,共3页
Journal of Modern Oncology
基金
河北省科技厅攻关项目(编号:03276117)